News
17h
Health and Me on MSNWegovy Approved For MASH Treatment With Fibrosis But No Cirrhosis
FDA has approved Novo Nordisk's Wegovy, one-weekly 2.4 mg semaglutide injection for treating metabolic-associated ...
Elexacaftor–tezacaftor–ivacaftor was linked to a 72% lower risk of severe liver complications in cystic fibrosis patients, ...
14hon MSN
89bio, Inc. (ETNB) Reports Second-Quarter Results; Leerink Partners and Citi Maintain ‘Buy’ Ratings
With significant hedge fund interest and a share price under $10, 89bio, Inc. (NASDAQ:ETNB) secures a spot on our list of the ...
Prosecutors charged Blair Hamilton Hayes, 61 with causing the death of 47-year-old Emma Jean Teague this March ...
The liver, a crucial organ, faces stress from toxins and poor lifestyle choices, leading to potential dysfunction. Early ...
16h
News-Medical.Net on MSNTargeting the adrenomedullin pathway may be a potential therapy for liver failure
Liver failure syndromes are characterized by a dysregulated immune response leading to immune paralysis. Adrenomedullin (ADM) ...
Chicago natives Ricky and Sonya Amack have opened what they call a healthier fast food restaurant. Amack’s kitchen is located ...
A Vietnamese study of cirrhotic patients with esophageal variceal bleeding finds no significant difference in outcomes ...
USA: A recent study published in Diabetes, Obesity and Metabolism has reported that the use of glucagon-like peptide-1 ...
Enforcement of universal screenings would easily prevent sickness, expenses and death but enforcement isn’t easy.
23h
News-Medical.Net on MSNFucosylation emerges as a key player in digestive inflammatory diseases and cancers
Fucosylation, a crucial post-translational modification, has emerged as a significant factor influencing digestive inflammatory diseases and cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results